Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,091,554
+$74,545 QoQ
Shares Held
6,965
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#594
of 1,603 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mezzasalma Advisors, LLC holds $4,153,666 across 4 Drug Manufacturers - General names. NVS ranks #2 (26.3% of the industry book) .
All Filings in NVS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,091,554 | 6,965 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,017,009 | 6,658 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $876,991 | 6,361 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $774,056 | 6,036 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $725,091 | 5,992 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $759,959 | 6,817 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $671,536 | 6,901 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $603,164 | 5,244 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $536,558 | 5,040 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $388,564 | 4,017 | Shares | Sole | 2024-04-19 | |
| 2021-06-30 | $203,556 | 2,231 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $220,116 | 2,331 | Shares | Sole | 2021-06-01 | |
| No filing history on record for this holder in this stock. | ||||||